Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine in Binge Eating Disorder and Comorbid Depressive Disorder
NCT00607789Phase 4Completed
- Sponsor
- University of Cincinnati
- Start
- Oct 2006
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of duloxetine in binge eating disorder (BED), major depressive disorder (MDD), sponsored by University of Cincinnati. Started Oct 2006; status: completed.
02
Drugs
duloxetine
03
Conditions
binge eating disorder (BED)major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00607789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00607789.